Review Article

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

Figure 9

Antibody. Wide-field endoscopic images collected in vivo of human esophageal adenocarcinoma (EAC) following topical administration of bevacizumab labeled with IRDye800. (a) White light (WL), (b) overlay (OV), and (c) fluorescence (FL) image from nonfocal lesion (arrow) is shown. Similar set of images are shown for (d–f) flat and (g–i) protruding EAC (reprinted and modified with the permission from [96]).
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)